Literature DB >> 24619166

Influence of different additives and their concentrations on corneal toxicity and antimicrobial effect of benzalkonium chloride.

Naoko Onizuka1, Masafumi Uematsu, Mao Kusano, Hitoshi Sasaki, Kiyoshi Suzuma, Takashi Kitaoka.   

Abstract

PURPOSE: The aim of this study was to examine the ophthalmic additives responsible for modulating acute corneal epithelial toxicity induced by benzalkonium chloride (BAC) and investigate the ability of polyoxyethylene hydrogenated castor oil 40 (HCO-40) and polysorbate 80 (PS-80) to reduce the corneal toxicity and antimicrobial effects of BAC.
METHODS: Cytotoxicity of the additives, which included glycerin, polyvinyl alcohol, propylene glycol, polyethylene glycol, and PS-80, on rabbit corneal epithelial cells was examined using the cell proliferation assay in the presence and absence of 0.02% BAC. The corneal transepithelial electrical resistance change after a 60-second exposure to HCO-40 or PS-80 mixed with 0.02% BAC was measured in living rabbits. Corneal damage was examined using scanning electron microscopy. The antimicrobial activities of HCO-40 and PS-80 with 0.02% BAC against Staphylococcus aureus, Propionibacterium acnes, Pseudomonas aeruginosa, Escherichia coli, and Streptococcus pneumoniae were assessed.
RESULTS: Of all the tested additives, only PS-80 could prevent the BAC-induced cytotoxicity. Corneal epithelial barrier function disorder caused by 0.02% BAC was significantly alleviated by either PS-80 or HCO-40 in a concentration-dependent manner. Scanning electron microscopy images showed an improvement of BAC-induced corneal epithelial toxicity after the addition of HCO-40 or PS-80. The antimicrobial effect of the BAC against P. aeruginosa, E. coli, and S. pneumoniae was reduced after adding HCO-40 or PS-80.
CONCLUSIONS: HCO-40 and PS-80 reduce acute corneal toxicity and the antimicrobial effect of BAC. Possible interactions between BAC and other additives should be taken into consideration when evaluating the toxicity and antibacterial properties of BAC.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24619166     DOI: 10.1097/ICO.0000000000000086

Source DB:  PubMed          Journal:  Cornea        ISSN: 0277-3740            Impact factor:   2.651


  7 in total

1.  Development of ciprofloxacin-loaded contact lenses using fluorous chemistry.

Authors:  Guoting Qin; Zhiling Zhu; Siheng Li; Alison M McDermott; Chengzhi Cai
Journal:  Biomaterials       Date:  2017-01-31       Impact factor: 12.479

2.  Effect of antibiotic prophylaxis on Coagulase-negative Staphylococcus virulence factor profiles in patients undergoing cataract surgery.

Authors:  Yolanda López; Margarita Samudio; Norma Fariña; Verónica Castillo; Sonia Abente; Martin M Nentwich; Nilsa González-Britez; Florentina Laspina; Agustín Carron; Diógenes Cibils; Herminia Miño de Kaspar
Journal:  Int Ophthalmol       Date:  2016-09-21       Impact factor: 2.031

3.  New micelle myricetin formulation for ocular delivery: improved stability, solubility, and ocular anti-inflammatory treatment.

Authors:  Fengyuan Sun; Zhou Zheng; Jie Lan; Xuefei Li; Mengshuang Li; Kaichao Song; Xianggen Wu
Journal:  Drug Deliv       Date:  2019-12       Impact factor: 6.419

4.  Biological and antimicrobial properties of the association Ambroxol and a water-soluble viscous liquid as a vehicle for a tricalcium silicate-based sealer.

Authors:  Índia Olinta de Azevedo Queiroz; Thiago Machado; Camila Carneiro Alves; Victor Gustavo Balera Brito; Bruno Carvalho de Vasconcelos; João Eduardo Gomes-Filho; Edilson Ervolino; Sandra Helena Penha de Oliveira; Marco Antonio Hungaro Duarte
Journal:  J Mater Sci Mater Med       Date:  2021-11-24       Impact factor: 3.896

Review 5.  Review: The Lacrimal Gland and Its Role in Dry Eye.

Authors:  Christopher D Conrady; Zachary P Joos; Bhupendra C K Patel
Journal:  J Ophthalmol       Date:  2016-03-02       Impact factor: 1.909

6.  Plasma rich in growth factors eye drops to treat secondary ocular surface disorders in patients with glaucoma.

Authors:  Ronald M Sánchez-Avila; Jesus Merayo-Lloves; Maria Laura Fernández; Luis Alberto Rodríguez-Gutiérrez; Pedro Pablo Rodríguez-Calvo; Andres Fernández-Vega Cueto; Francisco Muruzabal; Gorka Orive; Eduardo Anitua
Journal:  Int Med Case Rep J       Date:  2018-05-01

7.  Effects of Topical Thymoquinone in an Experimental Dry Eye Model

Authors:  Tolga Kocatürk; Erol Erkan; İbrahim Meteoğlu; Mehmet Ekici; Aslıhan Karul Büyüköztürk; İrfan Yavaşoğlu; Harun Çakmak; Volkan Dayanır; Muharrem Balkaya
Journal:  Turk J Ophthalmol       Date:  2018-12-27
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.